41 related articles for article (PubMed ID: 671430)
1. Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients.
Kaneko K; Chen H; Kaufman M; Sverdlov I; Stein EM; Park-Min KH
Clin Transl Med; 2021 Oct; 11(10):e526. PubMed ID: 34709753
[TBL] [Abstract][Full Text] [Related]
2. [Atypical arthritis of the hands : Collagenosis-part 1].
Bollow M
Radiologe; 2021 May; 61(5):458-469. PubMed ID: 33779767
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
Shaharir SS; Chua SH; Mohd R; Mustafar R; Noh MM; Shahril NS; Said MSM; Rajalingham S
PLoS One; 2021; 16(3):e0248845. PubMed ID: 33739994
[TBL] [Abstract][Full Text] [Related]
4. Avascular necrosis of the femoral head due to low-dose corticosteroid used in a patient with panhypopituitarism: A case report and literature review.
Çalapkulu M; Kızılgül M; Sencar ME; Düğer H; Uçan B; Çakal E; Özbek M
Jt Dis Relat Surg; 2020; 31(2):390-394. PubMed ID: 32584743
[TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis of the Hip: A Primer.
Lespasio MJ; Sodhi N; Mont MA
Perm J; 2019; 23():. PubMed ID: 30939270
[TBL] [Abstract][Full Text] [Related]
6. Bilateral femoral head avascular necrosis with a very low dose of oral corticosteroid used for panhypopituitarism.
Dharmshaktu P; Aggarwal A; Dutta D; Kulshreshtha B
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26762348
[TBL] [Abstract][Full Text] [Related]
7. High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review.
Mont MA; Pivec R; Banerjee S; Issa K; Elmallah RK; Jones LC
J Arthroplasty; 2015 Sep; 30(9):1506-1512.e5. PubMed ID: 25900167
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.
Sayarlioglu M; Yuzbasioglu N; Inanc M; Kamali S; Cefle A; Karaman O; Onat AM; Avan R; Cetin GY; Gul A; Ocal L; Aral O
Rheumatol Int; 2012 Jan; 32(1):177-82. PubMed ID: 20711782
[TBL] [Abstract][Full Text] [Related]
9. Steroid induced osteonecrosis: An analysis of steroid dosing risk.
Powell C; Chang C; Naguwa SM; Cheema G; Gershwin ME
Autoimmun Rev; 2010 Sep; 9(11):721-43. PubMed ID: 20621176
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy.
Haque W; Kadikoy H; Pacha O; Maliakkal J; Hoang V; Abdellatif A
Rheumatol Int; 2010 Apr; 30(6):719-23. PubMed ID: 20012628
[TBL] [Abstract][Full Text] [Related]
11. A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur.
Salesi M; Karimifar M; Mottaghi P; Sayedbonakdar Z; Karimzadeh H
Rheumatol Int; 2010 Feb; 30(4):527-9. PubMed ID: 19449187
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis in patients with SLE.
Abu-Shakra M; Buskila D; Shoenfeld Y
Clin Rev Allergy Immunol; 2003 Aug; 25(1):13-24. PubMed ID: 12794257
[TBL] [Abstract][Full Text] [Related]
13. Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: report of two cases.
Taccari E; Spadaro A; Riccieri V; Grandilli MA; Zoppini A
Clin Rheumatol; 1989 Sep; 8(3):386-92. PubMed ID: 2805614
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus: treatment and prognosis.
Hughes GR
Br Med J; 1979 Oct; 2(6197):1019-22. PubMed ID: 391327
[No Abstract] [Full Text] [Related]
15. Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE.
Dimant J; Ginzler EM; Diamond HS; Schlesinger M; Marino CT; Weiner M; Kaplan D
J Rheumatol; 1978; 5(2):136-41. PubMed ID: 671430
[TBL] [Abstract][Full Text] [Related]
16. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy.
Abeles M; Urman JD; Rothfield NF
Arch Intern Med; 1978 May; 138(5):750-4. PubMed ID: 646538
[TBL] [Abstract][Full Text] [Related]
17. Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation.
Weiner ES; Abeles M
J Rheumatol; 1989 May; 16(5):604-8. PubMed ID: 2666654
[TBL] [Abstract][Full Text] [Related]
18. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.
Fialho SC; Bonfá E; Vitule LF; D'Amico E; Caparbo V; Gualandro S; Pereira RM
Lupus; 2007; 16(4):239-44. PubMed ID: 17439929
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
